Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transformation Discriminant Analysis for Constructing Optimal Biomarker Combinations.

Statistics in medicine·2026
Same author

Phase-targeted auditory stimulation enhances slow-wave activity during sleep in Huntington's disease: A pilot crossover study.

Journal of Huntington's disease·2026
Same author

Sodium channel blockers are associated with reduced dementia risk in late-onset unexplained epilepsy.

medRxiv : the preprint server for health sciences·2026
Same author

Likelihood-based modeling of covariate-specific time-dependent receiver operating characteristic curves.

Statistical methods in medical research·2026
Same author

Rejoinder to the discussion on ''Nonparanormal Adjusted Marginal Inference''.

Biometrics·2026
Same author

Outcome associations of CSF total tau in suspected non-Alzheimer pathophysiology.

Journal of neurology·2026

Related Experiment Video

Updated: Apr 25, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K

RandomForest4Life: a Random Forest for predicting ALS disease progression.

Torsten Hothorn1, Hans H Jung

  • 1Institut für Sozial- und Präventivmedizin, Abteilung Biostatistik, Universität Zürich , Zürich.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|August 21, 2014
PubMed
Summary
This summary is machine-generated.

Predicting amyotrophic lateral sclerosis (ALS) progression is possible using past patient data. A random forest model showed that prior disease advancement and initial score variability strongly predict future ALS progression.

Keywords:
ALSFRSALSFRS-RPRO-ACTPrize4Lifeprognostic factorsscore ratioslope

More Related Videos

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

27.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.7K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

27.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Area of Science:

  • Neurology
  • Biostatistics
  • Computational Biology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • Accurate prediction of ALS progression is crucial for patient management and clinical trials.
  • Existing prediction models often lack sufficient accuracy and robustness.

Purpose of the Study:

  • To develop and validate a predictive model for ALS disease progression.
  • To identify key predictors of future disease advancement in ALS patients.
  • To evaluate the model's performance in an external validation setting.

Main Methods:

  • Utilized a random forest algorithm for prediction.
  • Employed longitudinal patient examination data over three months.
  • Trained and validated the model on data from 1197 ALS patients (PRO-ACT database).
  • Externally validated the model using data from 625 additional patients.

Main Results:

  • The developed method achieved third-best prediction accuracy in a challenge setting.
  • Past disease progression was confirmed as a significant predictor of future ALSFRS scores.
  • Greater variability in initial ALSFRS scores correlated with faster future disease progression.

Conclusions:

  • Random forest models can effectively predict ALS disease progression.
  • Multidimensional analysis of ALSFRS scores may enhance prediction accuracy.
  • The findings support the use of past progression and score variability as key predictive factors.